Intravenous Recombinant Tissue Plasminogen Activator Administered at Three to Six Hours Following Onset of Ischemic Stroke Does Not Improve Outcome. A Meta-Analysis

被引：0
|
作者：
Maiser, Samuel J.
Suri, M. Fareed K.
Georgiadis, Alexandros
Vazquez, Gabriela
Qureshi, Adnan
机构：
来源：
NEUROLOGY | 2009年 / 72卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A355 / A355
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of intravenous recombinant tissue plasminogen activator in acute ischemic stroke: Results of the ECASS three-hour cohort
    Hacke, W
    Toni, D
    Larrue, V
    vonKummer, R
    [J]. ANNALS OF NEUROLOGY, 1996, 40 (03) : M37 - M37
  • [22] Combined intravenous/intraarterial compared with Intraarterial recombinant tissue plasminogen activator in acute ischemic stroke: Propensity score analysis
    Zaidat, OO
    Welter, E
    Love, TE
    Tarr, RW
    Sunshine, JL
    Landis, DMD
    Selman, WR
    Enterline, DS
    Smith, TP
    Alexander, MJ
    [J]. JOURNAL OF NEUROSURGERY, 2004, 100 (01) : A181 - A181
  • [23] Mechanical Thrombectomy With and Without Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke: A Systematic Review and Meta-Analysis Using Nested Knowledge
    Adusumilli, Gautam
    Pederson, John M.
    Hardy, Nicole
    Kallmes, Kevin M.
    Hutchison, Kristen
    Kobeissi, Hassan
    Heiferman, Daniel M.
    Heit, Jeremy J.
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [24] Incidence of seizure in stroke patients treated with recombinant tissue plasminogen activator: A systematic review and meta-analysis
    Lekoubou, Alain
    Awoumou, Jean Joel
    Kengne, Andre Pascal
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2017, 12 (09) : 923 - 931
  • [25] Low-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
    Cheng, Ji-Wei
    Zhang, Xiao-Jing
    Cheng, Li-Shan
    Li, Guo-Yi
    Zhang, Li-Jun
    Ji, Kang-Xiang
    Zhao, Qing
    Bai, Yu
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (02): : 381 - 390
  • [26] Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
    Gyanendra Kumar
    Drew Uhrig
    Susan Fowler
    Matthew C. DeLaney
    Andrei V. Alexandrov
    [J]. CNS Drugs, 2015, 29 : 659 - 667
  • [27] Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
    Kumar, Gyanendra
    Uhrig, Drew
    Fowler, Susan
    DeLaney, Matthew C.
    Alexandrov, Andrei V.
    [J]. CNS DRUGS, 2015, 29 (08) : 659 - 667
  • [28] Prior antiplatelet agent use and outcomes after intravenous thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: a meta-analysis of cohort studies and randomized controlled trials
    Pan, Xiding
    Zhu, Yubing
    Zheng, Danni
    Liu, Yukai
    Yu, Feng
    Yang, Jie
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2015, 10 (03) : 317 - 323
  • [29] Analysis of the risk of hemorrhagic complications in acute ischemic stroke patients with microbleeds after intravenous recombinant tissue plasminogen activator therapy
    Takahashi, Y.
    Morihara, R.
    Narai, H.
    Omori, N.
    Manabe, Y.
    [J]. INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 57 - 58
  • [30] Low- versus Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke: An Updated Meta-Analysis
    Liu, Huihui
    Zheng, Huaguang
    Cao, Yongjun
    Pan, Yuesong
    Wang, David
    Zhang, Runhua
    You, Shoujiang
    Zhang, Xinmiao
    Li, Shuya
    Tong, Xu
    Liu, Chun-feng
    Wang, Yilong
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2018, 27 (04): : 988 - 997
12345